Dynavax Technologies (DVAX) Names Christine Larson as CFO
Tweet
Share
E-mailGet Alerts DVAX Hot Sheet
Join SI Premium – FREE
Dynavax Technologies Corporation (NASDAQ: DVAX) appointed Christine Larson to the position of Vice President and Chief Financial Officer, a newly created position.
Ms. Larson brings nearly 25 years of experience as a financial professional to the role, including a background in corporate finance and investment banking. Ms. Larson joins Dynavax from PDL Biopharma, Inc. (Nasdaq: PDLI), where she was responsible for leading financial and strategic planning, accounting, and treasury and investor relations
Ms. Larson brings nearly 25 years of experience as a financial professional to the role, including a background in corporate finance and investment banking. Ms. Larson joins Dynavax from PDL Biopharma, Inc. (Nasdaq: PDLI), where she was responsible for leading financial and strategic planning, accounting, and treasury and investor relations
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ProLogium names Rimac Group CEO Antony Sheriff to its board
- U.S. Bank names Chris Peary chief private banking officer
- AEON Biopharma names ex-FDA neuroscience official as acting CRO
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
